Finance

Lists
Why is EIKN up 3,85%?
Dive Deeper
EIKN:NASDAQ
Eikon Therapeutics Inc
7,28 $
+3,85%
(+0,27) 1D
15 հոկ, 11:16:13 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EIKN...
Open
7,01 $
High
7,33 $
Low
7,01 $
Mkt. cap
394,32 մլն
Avg. vol.
633,29 հզր
Volume
98,73 հզր
P/E ratio
0,14
52-wk high
17,40 $
52-wk low
6,45 $
EPS
53,57 $
No. of employees
384
Open
7,01 $
High
7,33 $
Low
7,01 $
Mkt. cap
394,32 մլն
Avg. vol.
633,29 հզր
Volume
98,73 հզր
P/E ratio
0,14
52-wk high
17,40 $
52-wk low
6,45 $
EPS
53,57 $
No. of employees
384
News stories
From web sources and news partners
About Eikon Therapeutics Inc
CEO-
Employees384
Founded2019
HeadquartersMillbrae, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websiteeikontx.com
Analyst ratings
Based on 3 analysts giving stock ratings to EIKN in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for EIKN in the last 3 months.
Highest
Current 7,28 $
32,00 $ (+339,56%)
Average
31,00 $ (+325,82%)
Lowest
29,00 $ (+298,35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Zemansky
Bank of America Securities
Buy
Maintained
32,00 $
+339,6%
09/28/2026
Sean Laaman
Morgan Stanley
Buy
Reiterated
32,00 $
+339,6%
08/17/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
29,00 $
+298,4%
08/17/2026
Robert Driscoll
Wedbush
Sell
Maintained
5,00 $
-31,3%
05/12/2026
Joseph Catanzaro
Mizuho Securities
Buy
Initiated
26,00 $
+257,1%
03/02/2026
Last report
13 օգս, 2026 թ.
Fiscal period
Q2 2026
-1,63 $ / -1,46 $
-11,54%miss
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
66,19 մլն
65,23 մլն
70,05 մլն
75,46 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,14 մլն
17,73 մլն
17,29 մլն
17,93 մլն
Operating expense
85,33 մլն
82,96 մլն
87,34 մլն
93,39 մլն
Total operating expenses
85,33 մլն
82,96 մլն
87,34 մլն
93,39 մլն
Operating income
-85,33 մլն
-82,96 մլն
-87,34 մլն
-93,39 մլն
Other non operating income
-2,00 հզր
-9,00 հզր
-1,00 հզր
-52,00 հզր
EBT including unusual items
-105,21 մլն
-79,66 մլն
-82,96 մլն
-88,41 մլն
EBT excluding unusual items
-80,90 մլն
-79,45 մլն
-82,96 մլն
-88,41 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-105,21 մլն
-79,66 մլն
-82,96 մլն
-88,41 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-26,23
-2,46
-1,63
Interest and investment income
4,43 մլն
3,52 մլն
4,38 մլն
5,04 մլն
Interest expense
-
-
-
-
Net interest expenses
4,43 մլն
3,52 մլն
4,38 մլն
5,04 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-81,12 մլն
-77,57 մլն
-82,12 մլն
-88,26 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps